Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06188455
What this trial is testing

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
The First Affiliated Hospital of Xiamen University 37
Not applicableUnknownNCT02164552
What this trial is testing

Vitamin D Status in Relation to Insulin Sensitivity Among Saudi Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
King Abdulaziz University 340
Not applicableStudy completedNCT04580433
What this trial is testing

Time-restricted Feeding for Treating Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeOverweightObesity
Chunzhu Li 18
Not applicableLooking for participantsNCT07070726
What this trial is testing

UNTOLD Ovarian Cancer Unmet Needs Survey

Who this might be right for
Ovarian Cancer
Masonic Cancer Center, University of Minnesota 2,000
Post-approval studies (Phase 4)Study completedNCT05465135
What this trial is testing

The Effect of Dihydroartemisinin in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Shanghai Zhongshan Hospital 19
Early research (Phase 1)Study completedNCT01478685
What this trial is testing

CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more
Celgene 169
Early research (Phase 1)Ended earlyNCT04315233
What this trial is testing

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Who this might be right for
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT00022347
What this trial is testing

TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Early research (Phase 1)Study completedNCT00003358
What this trial is testing

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 24
Not applicableStudy completedNCT05775549
What this trial is testing

Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
AstraZeneca 24
Testing effectiveness (Phase 2)Ended earlyNCT02101684
What this trial is testing

Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study.

Who this might be right for
Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors
Grupo Español de Tumores Huérfanos e Infrecuentes 10
Testing effectiveness (Phase 2)Ended earlyNCT01392352
What this trial is testing

HYPAZ: Hypertension Induced by Pazopanib

Who this might be right for
Renal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more
Cambridge University Hospitals NHS Foundation Trust 31
Not applicableStudy completedNCT03370952
What this trial is testing

Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH

Who this might be right for
Ovarian Cysts
Cairo University 112
Testing effectiveness (Phase 2)Study completedNCT03674385
What this trial is testing

Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate

Who this might be right for
Clomiphene Citrate Resistant Polycystic Ovary Syndrome
Ain Shams University 60
Not applicableWithdrawnNCT00323726
What this trial is testing

Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Who this might be right for
Ovarian Cancer
New Mexico Cancer Research Alliance
Not applicableUnknownNCT04300699
What this trial is testing

Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapyQuality of Life+2 more
Royal Marsden NHS Foundation Trust 120
Testing effectiveness (Phase 2)Study completedNCT05198804
What this trial is testing

Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerPlatinum-resistant Ovarian CancerPrimary Peritoneal Carcinoma+1 more
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 117
Not applicableLooking for participantsNCT06827353
What this trial is testing

Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency

Who this might be right for
Ovarian Carcinoma
Centre Hospitalier Universitaire de Nīmes 300
Not applicableStudy completedNCT01982500
What this trial is testing

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 200
Next Page